Does the Use of Rocuronium-Sugammadex Instead of Succinylcholine in Electroconvulsive Therapy Affect Seizure Duration?
Ceyhan Oflezer, Özge Atay, Zümrüt Ela Kaşdoğan, Gülay Özakay, Derya İpekçioğlu, Hakan Bahadır
Psychiatry Investig. 2022;19(10):824-831.   Published online 2022 Oct 21     DOI: https://doi.org/10.30773/pi.2022.0123
Current evidence on the use of sugammadex for neuromuscular blockade antagonism during electroconvulsive therapy: a narrative review
Vivek Arora, Laurence Henson, Sandeep Kataria
Korean Journal of Anesthesiology.2025; 78(1): 3.     CrossRef